FDA
approval
· 2023-10-20
FDA Approved: COXANTO — Original Application (SOLA Pharmaceuticals, LLC)
Summary
The FDA approved COXANTO (oxaprozin) from SOLA Pharmaceuticals in its original application, enabling its use for pain and inflammation associated with rheumatoi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for COXANTO (OXAPROZIN)